Evidence map›Paper›PMID 28039657›Full record

ArticleJournal of genetic counseling2017

Self-Reported Questionnaire Detects Family History of Cancer in a Pancreatic Cancer Screening Program.

Aimee L Lucas, Adam Tarlecki, Kellie Van Beck, Casey Lipton, Arindam RoyChoudhury, Elana Levinson, Sheila Kumar, Wendy K Chung, Harold Frucht, Jeanine M Genkinger

Open access · bronzeAbstract read
In one paragraph

Article in Journal of genetic counseling, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Aimee L LucasHenry D. Janowitz Division of Gastroenterology, Samuel Bronfman Department of Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1069, New York, NY, 10029, USA. aimee.lucas@mssm.edu.
Adam TarleckiDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, 10032, USA.
Kellie Van BeckDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, 10032, USA.
Casey LiptonDivision of Gastroenterology, Department of Medicine, Columbia University, New York, NY, 10032, USA.
Arindam RoyChoudhuryDepartment of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, 10032, USA.
Elana LevinsonCancer Genetics Program, New York Presbyterian Hospital, New York, NY, 10032, USA.
Sheila KumarNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.
Wendy K ChungDivision of Molecular Genetics, Department of Pediatrics, Columbia University, New York, NY, 10032, USA.
Harold FruchtDivision of Gastroenterology, Department of Medicine, Columbia University, New York, NY, 10032, USA.
Jeanine M GenkingerDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, 10032, USA.
Columbia University · USCancer Genetics (United States) · USIcahn School of Medicine at Mount Sinai · USNational Institute of Diabetes and Digestive and Kidney Diseases · US

Funding

Clinical and Translational Science AwardUL1TR000040 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2012 to 2015
$26.2M
Mount Sinai Institutes for Clinical and Translational SciencesUL1TR000067 · NCATS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SAMPSON, HUGH A · 2012 to 2014
$16.5M
NCATS NIH HHS UL1 TR000040NCATS NIH HHS UL1 TR000067
6 · The paper itself

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer death; approximately 5-10% of PDAC is hereditary. Self-administered health history questionnaires (HHQs) may provide a low-cost method to detail family history (FH) of malignancy. Pancreas Center patients were asked to enroll in a registry; 149 with PDAC completed a HHQ which included FH data. Patients with FH of PDAC, or concern for inherited PDAC syndrome, were separately evaluated in a Prevention Program and additionally met with a genetic counselor (GC) to assess PDAC risk (n = 61). FH obtained through GC and HHQ were compared using Wilcoxon signed-rank sum and generalized linear mixed models with Poisson distribution. Agreement between GC and HHQ risk-assessment was assessed using kappa (κ) statistic. In the Prevention Program, HHQ was as precise in detecting FH of cancer as the GC (all p > 0.05). GC and HHQ demonstrated substantial agreement in risk-stratification of the Prevention Program cohort (κ = 0.73, 95% CI 0.59-0.87.) The sensitivity of the HHQ to detect a patient at elevated risk (i.e., moderate- or high-risk) of PDAC, compared to GC, was 82.9% (95% CI 67.3-92.3%) with a specificity of 95% (95% CI 73.1-99.7%). However, seven patients who were classified as average-risk by the HHQ were found to be at an elevated-risk of PDAC by the GC. In the PDAC cohort, 30/149 (20.1%) reported at least one first-degree relative (FDR) with PDAC. The limited sensitivity of the HHQ to detect patients at elevated risk of PDAC in the Prevention Program cohort suggests that a GC adds value in risk-assessment in this population. The HHQ may offer an opportunity to identify high-risk patients in a PDAC population.

Indexed as

Early Detection of CancerMedical History TakingSelf ReportAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedPancreatic NeoplasmsSensitivity and SpecificitySurveys and QuestionnairesGenetic counselorHealth history questionnaireHereditary pancreatic cancerPancreatic cancerPancreatic ductal adenocarcinoma

Identifiers

PMID28039657
PMCPMC5498249
OpenAlexW2565697108

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.